Issue 153

26.06.2020

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

Highlights

Europe

PROHIBITION PARTNERS LIVE

 

 

Missed out on Prohibition Partners LIVE? Not to worry, you can access all 120 hours of virtual debate, market intelligence and consumer data via our on-demand platform.

We highly recommend watching Protecting the Consumer: CBD in Europe (Cannabis Europa), Building Successful Cannabis Brands (Cannabis Americana), and What Lies Ahead? The Future of Therapy (The PSYCH Symposium).

Access all the content now for 30 days for as little as $59 (£47/€53).

BUY NOW

USA

Canada

Latam & Caribbean

APAC

Africa & Middle East

Health & Science

Psychedelics

FEATURE

 

 

Health insurance cannabis sales in Germany soared in Q1 2020, reaching a new record high of almost €15 million in March, more than 50% above the €9.5m of a year before.

The exceptionally good results in March 2020 may reflect some patients redeeming their prescriptions earlier to cope with the COVID-19 crisis, similar to the stockpiling seen in North American markets during March.

Read the full analysis from Prohibition Partners here.

READ NOW